153 related articles for article (PubMed ID: 31010836)
1. Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics.
Xing D; Zheng G; Pallavajjala A; Schoolmeester JK; Liu Y; Haley L; Hu Y; Liu L; Logan L; Lin Y; Pearce KE; Sattler CA; Tsai YC; Vang R; Hung CF; Wu TC; Ronnett BM
Clin Cancer Res; 2019 Jul; 25(14):4516-4529. PubMed ID: 31010836
[TBL] [Abstract][Full Text] [Related]
2. Choriocarcinoma in Women: Analysis of a Case Series With Genotyping.
Savage J; Adams E; Veras E; Murphy KM; Ronnett BM
Am J Surg Pathol; 2017 Dec; 41(12):1593-1606. PubMed ID: 28877059
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence In Situ Hybridization for the X and Y Chromosome Centromeres Helps Differentiate Between Gestational and Nongestational Choriocarcinoma in Clinically Ambiguous Cases.
Whaley RD; Dougherty RE; Cheng L; Ulbright TM
Arch Pathol Lab Med; 2020 Jul; 144(7):863-868. PubMed ID: 31846368
[TBL] [Abstract][Full Text] [Related]
4. Use of short tandem repeat analysis in unusual presentations of trophoblastic tumors and their mimics.
Aranake-Chrisinger J; Huettner PC; Hagemann AR; Pfeifer JD
Hum Pathol; 2016 Jun; 52():92-100. PubMed ID: 26980014
[TBL] [Abstract][Full Text] [Related]
5. Ovarian Intermediate Trophoblastic Tumors: Genotyping Defines a Distinct Category of Nongestational Tumors of Germ Cell Type.
Xing D; Zhong M; Ye F; O'Malley MT; Li S; Vang R; Ronnett BM
Am J Surg Pathol; 2020 Apr; 44(4):516-525. PubMed ID: 31688005
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 Expression in Carcinosarcomas of the Gynecologic Tract: A Potentially Actionable Biomarker.
Pinto A; Mackrides N; Nadji M
Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):393-397. PubMed ID: 27801734
[TBL] [Abstract][Full Text] [Related]
7. Intermediate trophoblast in germ cell neoplasms.
Manivel JC; Niehans G; Wick MR; Dehner LP
Am J Surg Pathol; 1987 Sep; 11(9):693-701. PubMed ID: 2820253
[TBL] [Abstract][Full Text] [Related]
8. Mixed serous carcinoma of the endometrium with trophoblastic differentiation: analysis of the p53 tumor suppressor gene suggests stem cell origin.
Horn LC; Hänel C; Bartholdt E; Dietel J
Ann Diagn Pathol; 2008 Feb; 12(1):1-3. PubMed ID: 18164407
[TBL] [Abstract][Full Text] [Related]
9. Analysis of PD-L1 expression in trophoblastic tissues and tumors.
Lu B; Teng X; Fu G; Bao L; Tang J; Shi H; Lu W; Lu Y
Hum Pathol; 2019 Feb; 84():202-212. PubMed ID: 30339966
[TBL] [Abstract][Full Text] [Related]
10. An Overview of the Role of Long Non-Coding RNAs in Human Choriocarcinoma.
Di Fiore R; Suleiman S; Felix A; O'Toole SA; O'Leary JJ; Ward MP; Beirne J; Sabol M; Ozretić P; Yordanov A; Vasileva-Slaveva M; Kostov S; Nikolova M; Said-Huntingford I; Ayers D; Ellul B; Pentimalli F; Giordano A; Calleja-Agius J
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204445
[TBL] [Abstract][Full Text] [Related]
11. Uterine choriocarcinoma arising from serous carcinoma in a postmenopausal woman: an analysis of next-generation sequencing and PD-L1 immunochemistry.
Li M; Bao L; Lu B; Ge W; Ren L
Diagn Pathol; 2022 Oct; 17(1):79. PubMed ID: 36229840
[TBL] [Abstract][Full Text] [Related]
12. Using short tandem repeat analysis for choriocarcinoma diagnosis: a case series.
Zhang X; Yan K; Chen J; Xie X
Diagn Pathol; 2019 Aug; 14(1):93. PubMed ID: 31421690
[TBL] [Abstract][Full Text] [Related]
13. Gestational and nongestational trophoblastic tumors distinguished by DNA analysis.
Fisher RA; Newlands ES; Jeffreys AJ; Boxer GM; Begent RH; Rustin GJ; Bagshawe KD
Cancer; 1992 Feb; 69(3):839-45. PubMed ID: 1346098
[TBL] [Abstract][Full Text] [Related]
14. Expression of HOX gene products in normal and abnormal trophoblastic tissue.
Amesse LS; Moulton R; Zhang YM; Pfaff-Amesse T
Gynecol Oncol; 2003 Sep; 90(3):512-8. PubMed ID: 13678718
[TBL] [Abstract][Full Text] [Related]
15. Rectal adenocarcinoma with choriocarcinomatous differentiation: clinical and genetic aspects.
Verbeek W; Schulten HJ; Sperling M; Tiesmeier J; Stoop H; Dinjens W; Looijenga L; Wörmann B; Füzesi L; Donhuijsen K
Hum Pathol; 2004 Nov; 35(11):1427-30. PubMed ID: 15668903
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.
Cierna Z; Mego M; Miskovska V; Machalekova K; Chovanec M; Svetlovska D; Hainova K; Rejlekova K; Macak D; Spanik S; Ondrus D; Kajo K; Mardiak J; Babal P
Ann Oncol; 2016 Feb; 27(2):300-5. PubMed ID: 26598537
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profile of a newly established choriocarcinoma cell line, iC3-1, compared to existing choriocarcinoma cell lines and normal placenta.
Kobayashi Y; Banno K; Shimizu T; Ueki A; Tsuji K; Masuda K; Kisu I; Nomura H; Tominaga E; Nagano O; Saya H; Aoki D
Placenta; 2013 Feb; 34(2):110-8. PubMed ID: 23199791
[TBL] [Abstract][Full Text] [Related]
18. Nongestational choriocarcinoma in the postpartum period: a case report.
Suryanarayan K; O'Hanlan KA; Surti U; Ishwad CS; Nowels K; Letourneau D; Marina N
J Pediatr Hematol Oncol; 1998; 20(2):169-73. PubMed ID: 9544172
[TBL] [Abstract][Full Text] [Related]
19. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE
Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674
[TBL] [Abstract][Full Text] [Related]
20. Primary pure choriocarcinoma of the ovary in reproductive ages: a case report.
Simşek T; Trak B; Tunç M; Karaveli S; Uner M; Sönmez C
Eur J Gynaecol Oncol; 1998; 19(3):284-6. PubMed ID: 9641232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
